Technology | Clinical Decision Support | November 13, 2015

Platform uses current ordering behavior to provide insight on the operational and financial impact of using CDS

MedCurrent Impact, clinical decision support, CDS, ROI, return on investment, RSNA 2015

Image courtesy of Barco


November 13, 2015 — At this year’s annual meeting of the Radiological Society of North America (RSNA), MedCurrent will introduce a new tool that enables organizations to prospectively understand the impact and return on investment (ROI) of implementing clinical decision support (CDS). CDS will soon become a requirement as a result of the Centers for Medicare and Medicaid Services (CMS) mandate for hospital radiology departments and imaging centers.

MedCurrent Impact is a tool that can be integrated with an organization’s electronic health record (EHR) system to evaluate baseline order appropriateness and optimality. Furthermore, the captured data is analyzed and presented through MedCurrent’s Analytics platform to illustrate modality volume shifts and interactive ROI calculations, enabling the organization to understand better the impact of implementing CDS on local operations and finances. The resulting data and knowledge will bolster relevant strategic planning initiatives and ensure a more customized enterprise-wide CDS implementation.

Additionally, a solution like MedCurrent Impact can provide organizations with a low-cost option to interact with initiatives designed to comply with the CDS mandate while allowing them to work simultaneously toward full compliance. MedCurrent’s tool can forecast projected shifts in modality traffic, for example, which can inform workflow planning, resource allocation and technology procurement.

CDS software uses appropriate use criteria (AUC) to analyze and rank the appropriateness of a provider’s diagnostic imaging orders based on each patient’s clinical scenario. Research has demonstrated the ability of CDS to reduce the number of inappropriate exams, thereby improving quality, reducing costs and reducing unnecessary patient exposure to radiation.

For more information: www.medcurrent.com


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
Sponsored Content | Case Study | Enterprise Imaging

Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now